Clinical Trials on Graft-versus-host-disease in Canada
Total 1938 results
-
Lee DupuisC17 CouncilCompletedAcute-graft-versus-host DiseaseCanada
-
AHS Cancer Control AlbertaRecruitingRelapse | Graft-versus-host-diseaseCanada
-
Genentech, Inc.TerminatedAcute Graft-versus-host DiseaseUnited States, Canada
-
University Health Network, TorontoHoffmann-La RocheTerminatedGraft Versus Host DiseaseCanada
-
Fundación Pública Andaluza para la gestión de la...Instituto de Salud Carlos IIIActive, not recruitingGraft-versus-host DiseaseSpain
-
Jazz PharmaceuticalsCompletedAcute-graft-versus-host Disease | Graft-versus-host DiseaseUnited States, Belgium, United Kingdom, Greece, Germany, Spain, France, Italy, Austria, Canada, Bulgaria, Croatia, Poland, Portugal
-
Andalusian Initiative for Advanced Therapies -...Iniciativa Andaluza en Terapias AvanzadasCompletedImmune System Diseases | Graft Versus Host Disease | Chronic and Expanded Graft Versus Host DiseaseSpain
-
MallinckrodtPRA Health SciencesTerminatedAcute Graft-versus-Host DiseaseUnited States, Canada, Germany, United Kingdom, Australia, Austria, Belgium, Italy, France, Netherlands, Switzerland
-
Novartis PharmaceuticalsCompletedAcute Graft Versus Host DiseaseBelgium, Japan, Spain, France, Korea, Republic of, Canada, Italy, Denmark
-
EquilliumBiocon LimitedRecruitingGraft Versus Host Disease | GVHD | aGVHD | Acute-graft-versus-host Disease | Acute GVHDUnited States, Korea, Republic of, Israel, Spain, Germany, Belgium, Italy, Australia, France, Canada, Portugal
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States, Spain, Belgium, France, Italy, Korea, Republic of, Finland, United Kingdom, Germany, Israel, Switzerland, Austria, Australia, Czechia, Greece, New Zealand, Poland, Portugal, Taiwan
-
Gilead SciencesTerminatedChronic Graft Versus Host DiseaseSpain, Korea, Republic of, United States, Germany, Canada, France, United Kingdom
-
MaaT PharmaRecruitingAcute Graft Versus Host Disease in Intestine | Steroid Refractory GVHDSpain, France, Germany, Austria, Belgium, Italy
-
Mesoblast, Inc.CompletedGraft Versus Host DiseaseUnited States, Australia, Canada
-
Mesoblast, Inc.CompletedGraft Versus Host DiseaseUnited States, Italy, Australia, Canada, Switzerland, United Kingdom
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedGraft Versus Host DiseaseUnited States, Canada, Australia, Switzerland, Puerto Rico, New Zealand
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedChronic Graft Versus Host DiseaseUnited States, Australia, Austria, Canada, China, Croatia, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Singapore, Spain, Taiwan
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)Belgium, Italy, Spain, Saudi Arabia, Turkey, United Kingdom, Germany, Greece, Canada, Austria, France, Israel, Netherlands, Sweden, Switzerland, Korea, Republic of, Bulgaria, Japan, Norway, Czechia, Russian Federation, Jordan, Hungary, Ind... and more
-
University Health Network, TorontoBayerCompletedAlemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell TransplantsBone Marrow Transplantation | Graft Versus Host DiseaseCanada
-
McMaster UniversitySanofi; Ozmosis Research Inc.; Cell Therapy Transplant CanadaRecruitingAcute Leukemia | Myelodysplasia | Chronic Graft-versus-host-diseaseCanada, Australia
-
Millennium Pharmaceuticals, Inc.CompletedHematopoietic Stem CellsUnited States, Spain, Taiwan, Australia, Canada, Singapore, Korea, Republic of, Mexico, Switzerland, Japan, Germany, Norway, Israel, Russian Federation, Hungary, United Kingdom, Italy, Romania, Brazil, France, Austria, Belgium, Port... and more
-
Mesoblast, Inc.No longer availableGraft vs Host Disease | Graft-Versus-Host DiseaseUnited States, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingLymphoma | Leukemia | Hematopoietic and Lymphoid System NeoplasmUnited States, Canada
-
University of CalgaryAlberta Health services; University of AlbertaTerminated
-
University Health Network, TorontoActive, not recruiting
-
Syndax PharmaceuticalsActive, not recruitingChronic Graft-versus-host-diseaseKorea, Republic of, United States, Spain, Taiwan, France, Singapore, Belgium, Germany, Italy, Canada, Israel, Australia, United Kingdom, Greece, Poland, Portugal
-
Incyte CorporationTerminatedChronic Graft-versus-host DiseaseUnited States, Spain, France, Canada, Israel, United Kingdom, Germany, Italy, Denmark, Sweden, Finland, Belgium, Poland, Greece, Austria, Switzerland
-
Stanford UniversityNovartisCompletedLymphoma, Non-Hodgkin | Lymphoma, T-Cell, Peripheral | Bone Marrow Transplant FailureUnited States, Canada
-
University of British ColumbiaActive, not recruitingChronic Graft vs Host DiseaseCanada, United States, Austria
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)RecruitingChronic Graft Versus Host DiseaseUnited States, Canada
-
Incyte CorporationActive, not recruitingChronic Graft Versus Host Disease | Myelofibrosis | Postlung Transplant (Bronchiolitis Obliterans)United States, Spain, Italy, Germany, Belgium, Austria, Israel, Canada, Greece
-
Martin, PaulNational Cancer Institute (NCI)TerminatedCancerUnited States, Canada
-
University of British ColumbiaRecruitingLeukemia | Allogeneic Hematopoietic Stem Cell Transplantation | Blood Cancer | Chronic Graft-versus-Host-Disease | Non-Malignant Hematologic and Lymphocytic DisorderUnited States, Canada
-
SanofiRecruitingChronic Graft Versus Host DiseaseAustralia, Spain, Sweden, Czechia, United Kingdom, United States, Italy, Germany, Canada, Israel, Belgium, Denmark
-
Pharmacyclics LLC.Janssen Research & Development, LLCActive, not recruitingChronic Graft Versus Host DiseaseUnited States, Spain, Korea, Republic of, Australia, Austria, Canada, France, Germany, Israel, Italy, Netherlands, Russian Federation, United Kingdom
-
University of British ColumbiaRecruitingLeukemia | Allogeneic Hematopoietic Stem Cell Transplantation | Blood Cancer | Chronic Graft-versus-Host-Disease | Non-Malignant Hematologic and Lymphocytic DisorderUnited States, Canada
-
John LevineRecruitingAdverse Effects | Acute Graft vs Host Disease | Allogeneic Bone Marrow TransplantationUnited States, Canada
-
Novartis PharmaceuticalsActive, not recruitingGraft vs Host DiseaseJapan, Slovakia, Taiwan, Spain, Korea, Republic of, Thailand, Canada, Russian Federation, Italy, Turkey, India, Czechia, Brazil, Switzerland
-
Novartis PharmaceuticalsCompletedCorticosteroid Refractory Acute Graft vs Host DiseaseGermany, Japan, Saudi Arabia, Turkey, United Kingdom, Spain, Canada, Italy, Australia, Austria, France, Korea, Republic of, Hong Kong, Israel, Netherlands, Russian Federation, Denmark, Greece, Taiwan, Norway, Czechia, Bulgaria
-
Kiadis PharmaCompletedGraft vs Host DiseaseCanada
-
National Cancer Institute (NCI)Recruiting
-
Boston Children's HospitalFDA Office of Orphan Products DevelopmentActive, not recruiting
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedKidney Transplantation | Graft vs Host DiseaseCanada, United States
-
Genzyme, a Sanofi CompanyCompletedAcute Myelogenous Leukemia (AML) | Acute Lymphocytic Leukemia (ALL) | Graft vs. Host Disease (GvHD)United States, Canada
-
University of CalgaryCompletedPleural Effusions Post Coronary Artery Bypass GraftCanada
-
The Canadian Blood and Marrow Transplant GroupNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Graft Versus Host Disease | Secondary MyelofibrosisAustralia, Canada, United States, New Zealand, Saudi Arabia
-
Lumen TherapeuticsTerminated
-
Pharmacyclics Switzerland GmbHJanssen Biotech, Inc., including Johnson & JohnsonEnrolling by invitationLymphoma, B-Cell | Lymphoma, Non-Hodgkin | Solid Tumor | Leukemia, B-cell | Graft Vs Host DiseaseUnited States, Spain, Taiwan, United Kingdom, Australia, Italy, Russian Federation, Canada, New Zealand, Korea, Republic of, France, Turkey, Czechia, Hungary, Poland, Sweden
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedChildhood Acute Lymphoblastic Leukemia in Remission | Graft Versus Host Disease | B-cell Childhood Acute Lymphoblastic Leukemia | L1 Childhood Acute Lymphoblastic Leukemia | L2 Childhood Acute Lymphoblastic Leukemia | T-cell Childhood Acute Lymphoblastic LeukemiaUnited States, Canada, Australia
-
University Health Network, TorontoCompletedMyelodysplastic/Myeloproliferative Neoplasm | Allogeneic Hematopoietic Cell Transplant | Steroid Refractory GVHDCanada